Business Description
OSI Systems, Inc. designs and manufactures electronic systems and components worldwide. It operates in three segments: Security, Healthcare, and Optoelectronics and Manufacturing. The Security segment offers baggage and parcel inspection, cargo and vehicle inspection, hold baggage and people screening, radiation detection, and explosive and narcotics trace detection systems under the Rapiscan Systems, AS&E, and Gatekeeper names. It also provides site design, installation, training, and technical support services; and security screening solutions under the S2 name. The Healthcare segment offers patient monitoring and diagnostic cardiology systems, and related supplies and accessories under the Spacelabs name for use in critical care, emergency, and perioperative areas within hospitals, physicians' offices, medical clinics, and ambulatory surgery centers. The Optoelectronics and Manufacturing segment provides optoelectronic devices under the OSI Optoelectronics, OSI LaserDiode, OSI Laserscan, Semicoa, and Advanced Photonix names for the aerospace and defense, avionics, medical imaging and diagnostics, biochemistry analysis, pharmaceutical, nanotechnology, telecommunications, construction, and homeland security markets. It also offers electronics manufacturing services to original equipment manufacturers and end users for medical, automotive, defense, aerospace, industrial, and consumer applications under the OSI Electronics, APlus Products, Altaflex, and PFC names; and LCD displays for medical, industrial, and consumer electronics applications, as well as flex circuits for OEM customers. This segment offers laser-based remote sensing devices to detect and classify vehicles in toll and traffic management systems under the OSI Laserscan and Autosense names; and solid-state laser products for aerospace, defense, telecommunication, and medical applications under the OSI LaserDiode name. The company was incorporated in 1987 and is headquartered in Hawthorne, California.
Business History
Price Overview
Last updated: May 11, 2026 1:51pm (just now)Price History (1 Year)
Revenue & Net Income Trend
| Period | Revenue | Net Income | Net Margin | YoY/QoQ |
|---|
Key Metrics
EPS (Diluted): 8.91
Total Equity: $951.08M
Shares: 17,178,000
Total Debt: $649.63M
Cash: $106.41M
EBITDA: $261.10M
Total Debt: $649.63M
Cash: $106.41M
Revenue: $1.71B
Revenue: $1.71B
Revenue: $1.71B
Total Equity: $951.08M
Tax Rate: 19.6%
Equity: $951.08M
Total Debt: $649.63M
Cash: $106.41M
Current Liabilities: $696.94M
Long-Term Debt: $463.50M
Total Debt: $649.63M
Total Equity: $951.08M
Shares: 17,178,000
Shares: 17,178,000
CapEx: -$41.50M
Shares: 17,178,000
Stock Price: $235.91
Net Income: $149.64M
Industry Benchmarks
Deep Analysis
Pre-flight intelligence scans the company first, then routes to the right analytical methods.
Income Statement (Annual)
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $1.1B | $1.2B | $1.3B | $1.5B | $1.7B |
| Cost of Revenue | $727.0M | $758.8M | $847.9M | $1.0B | $1.1B |
| Gross Profit | $419.9M | $424.4M | $430.5M | $530.5M | $587.2M |
| Operating Expenses | $304.5M | $302.7M | $295.2M | $341.4M | $369.7M |
| Operating Income | $115.4M | $121.7M | $135.3M | $189.1M | $217.5M |
| Net Income | $74.0M | $115.3M | $91.8M | $128.2M | $149.6M |
| EBITDA | $159.2M | $168.0M | $173.8M | $230.7M | $261.1M |
| EPS | $4.12 | $6.57 | $5.45 | $7.55 | $8.91 |
| EPS (Diluted) | — | — | — | — | — |
Balance Sheet (Annual)
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | $80.6M | $64.2M | $76.8M | $95.4M | $106.4M |
| Total Current Assets | $709.4M | $746.1M | $839.9M | $1.2B | $1.4B |
| Total Assets | $1.4B | $1.4B | $1.6B | $1.9B | $2.2B |
| Current Liabilities | $344.8M | $614.0M | $571.7M | $814.6M | $696.9M |
| Long-Term Debt | $276.4M | $48.7M | $136.5M | $129.4M | $463.5M |
| Total Liabilities | $744.5M | $804.7M | $829.5M | $1.1B | $1.3B |
| Total Equity | $639.8M | $638.4M | $726.2M | $863.5M | $951.1M |
| Retained Earnings | $548.8M | $663.9M | $736.0M | $861.2M | $942.3M |
Cash Flow (Annual)
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Operating Cash Flow | $139.1M | $63.8M | $94.8M | -$87.5M | $97.6M |
| Capital Expenditure | -$29.5M | -$30.5M | -$32.3M | -$39.4M | -$41.5M |
| Free Cash Flow | $109.6M | $33.3M | $62.6M | -$126.9M | $56.1M |
| Acquisitions (net) | -$3.0M | -$14.1M | -$7.1M | -$9.0M | -$76.7M |
| Debt Repayment | — | — | — | — | — |
| Dividends Paid | — | — | — | — | — |
| Stock Buybacks | -$37.5M | -$111.6M | -$34.7M | $0 | -$80.4M |
| Net Change in Cash | $4.5M | -$16.4M | $12.5M | $18.6M | $11.1M |
Analyst Estimates (Annual)
| Metric | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| Revenue |
$1.7B $1.7B – $1.7B
|
$1.8B $1.8B – $1.9B
|
$1.9B $1.9B – $2.0B
|
$2.1B $2.1B – $2.1B
|
| EBITDA |
$245.2M $243.7M – $246.6M
|
$263.3M $260.9M – $267.6M
|
$279.2M $274.9M – $282.1M
|
$298.6M $298.6M – $298.6M
|
| Net Income |
$160.2M $158.2M – $162.3M
|
$178.9M $178.0M – $179.8M
|
$197.1M $191.5M – $202.7M
|
$228.3M $222.5M – $234.0M
|
| EPS | — | — | — | — |
Growth Trends (YoY %)
| Metric | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Revenue Growth | +3.2% | +8.0% | +20.4% | +11.3% |
| Gross Profit Growth | +1.1% | +1.4% | +23.2% | +10.7% |
| Operating Income Growth | +5.5% | +11.1% | +39.8% | +15.1% |
| Net Income Growth | +55.8% | -20.4% | +39.6% | +16.8% |
| EBITDA Growth | +5.5% | +3.5% | +32.8% | +13.2% |
Insider Trading (Recent)
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| 2026-05-04 | CHOPRA DEEPAK | S-Sale | 20,000.00 | $281.84 | $5.6M |
| 2026-04-23 | Constantine W Paul | F-InKind | 65.00 | $292.52 | $19,014 |
| 2026-02-02 | CHOPRA DEEPAK | S-Sale | 20,000.00 | $250.91 | $5.0M |
| 2025-12-31 | Constantine W Paul | A-Award | 55.00 | $192.73 | $10,600 |
| 2025-12-31 | SZE VICTOR S | A-Award | 75.00 | $140.61 | $10,546 |
| 2025-12-31 | Morben Paul Keith | A-Award | 75.00 | $140.61 | $10,546 |
| 2025-12-31 | Tropeano Michael | A-Award | 75.00 | $140.61 | $10,546 |
| 2025-12-31 | CHOPRA DEEPAK | A-Award | 75.00 | $140.61 | $10,546 |
| 2025-12-31 | Okawa Cary M. | A-Award | 52.00 | $109.61 | $5,700 |
| 2025-12-31 | EDRICK ALAN I | A-Award | 75.00 | $140.61 | $10,546 |
| 2025-12-31 | MEHRA AJAY | A-Award | 75.00 | $140.61 | $10,546 |
| 2025-12-23 | EDRICK ALAN I | G-Gift | 1,500.00 | $0.00 | $0 |
| 2025-12-13 | HAWKINS JAMES B | F-InKind | 15.00 | $259.44 | $3,892 |
| 2025-12-12 | SZE VICTOR S | G-Gift | 251.00 | $0.00 | $0 |
| 2025-12-11 | MEHRA AJAY | G-Gift | 3,000.00 | $0.00 | $0 |
| 2025-12-02 | Constantine W Paul | A-Award | 470.00 | $266.17 | $125,100 |
| 2025-11-22 | Okawa Cary M. | F-InKind | 26.00 | $251.10 | $6,529 |
| 2025-11-10 | CHOPRA DEEPAK | S-Sale | 20,000.00 | $285.74 | $5.7M |
| 2025-11-07 | Morben Paul Keith | S-Sale | 416.00 | $279.10 | $116,106 |
| 2025-11-07 | HAWKINS JAMES B | S-Sale | 1,500.00 | $283.15 | $424,725 |